1. Home
  2. LGO vs THAR Comparison

LGO vs THAR Comparison

Compare LGO & THAR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

LGO

Largo Inc.

HOLD

Current Price

$0.95

Market Cap

95.8M

Sector

N/A

ML Signal

HOLD

Logo Tharimmune Inc.

THAR

Tharimmune Inc.

HOLD

Current Price

$2.42

Market Cap

82.7M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
LGO
THAR
Founded
1988
2017
Country
Canada
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
95.8M
82.7M
IPO Year
2007
2022

Fundamental Metrics

Financial Performance
Metric
LGO
THAR
Price
$0.95
$2.42
Analyst Decision
Strong Buy
Analyst Count
2
0
Target Price
$3.30
N/A
AVG Volume (30 Days)
377.3K
340.9K
Earning Date
11-12-2025
11-12-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$111,884,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$53.91
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.85
$0.95
52 Week High
$2.70
$9.08

Technical Indicators

Market Signals
Indicator
LGO
THAR
Relative Strength Index (RSI) 42.13 42.90
Support Level $0.88 $2.20
Resistance Level $1.11 $2.57
Average True Range (ATR) 0.07 0.17
MACD 0.00 0.00
Stochastic Oscillator 26.98 30.91

Price Performance

Historical Comparison
LGO
THAR

About LGO Largo Inc.

Largo Inc is committed to the production and supply of high-quality vanadium products. The company is also focused on the advancement of renewable energy storage solutions through Largo Clean Energy and its vanadium redox flow battery technology. The Company is engaged in the mining, exploration, and development of mineral properties, predominantly in Brazil, through which it produces and supplies vanadium products VPURE Flake, VPURE+ Flake, and VPURE+ Powder. The company has operating segments: sales & trading, mine properties, which generates key revenue, corporate, exploration and evaluation properties, Clean Energy, and Largo Physical Vanadium.

About THAR Tharimmune Inc.

Tharimmune Inc is a biotechnology company developing a portfolio of therapeutic candidates for rare immune, inflammatory, and oncologic diseases. The Company is progressing towards acquiring a clinical-stage asset known to suppress chronic, debilitating pruritis or uncontrollable itching in primary biliary cholangitis (PBC), a rare orphan liver disease with no known cure. The Company's early-stage immuno-oncology pipeline includes novel multi-specific antibodies targeting epitopes with novel mechanisms of action against validated targets in multiple solid tumors.

Share on Social Networks: